The #1 most cited and #1 largest open-access journal in Immunology
Frontiers in Immunology promises to exert a paradigm shift in immunological publishing. It is a new and novel way to disseminate research findings and facilitate communication, both among scientists as well as the community at large. In the tradition of Edward Jenner, the publishing format is “open access”, meaning that the author pays for the publication rather than the reader, so that the publication is freely available to all - worldwide.
Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field. Immunology has evolved only within the past century, and the science itself has changed from initial experiments in the first half of the 20th century using whole animals, to the in vitro identification, enumeration and manipulation of the various cells comprising the system in the 1960s and 1970s, to the identification of the important molecules that are responsible for directing the behavior and function of the cells in the 1980s, to genetic approaches altering the expression of the molecules in whole animals since the 1990s. As such, there is now a fairly complete picture of what happens when an antigen is introduced. However, exactly how the changes in the molecules direct changes in the cells, and how the systemic immune response is organized, regulated and orchestrated remain obscure. Thus, in immunology, the work of Linnaeus has been accomplished; now the work of Darwin begins.
Frontiers in Immunology is the official journal of the IUIS.
Frontiers in Immunology is a member of the Committee on Publication Ethics.
Short Name: Front. Immunol.
Electronic ISSN: 1664-3224
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef
PMCID: all published articles receive a PMCID
Frontiers in Immunology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Immunology welcome submission of the following article types: Book Review, Case Report, Classification, Clinical Study Protocol, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Technology Report, Protocols and Specialty Grand Challenge.
When submitting a manuscript to Frontiers in Immunology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Immunology.